 |
|
|
| |
Pharmacokinetics of Bemnifosbuvir in Participants with Hepatic Impairment
|
| |
| |
EASL 2025 May 7-10 Amsterdam
Xiao-Jian Zhou,1 Thomas Marbury,2 Juan Carlos Rondon,3 William Smith,4 Maureen Montrond,1
Shannan Lynch,1 Keith Pietropaolo,1
Bruce Belanger,1 Maria Arantxa Horga,1 and Janet Hammond1
1. Atea Pharmaceuticals Inc, Boston, USA; 2. Orlando Clinical Research Center, Orlando, USA;
3. Clinical Pharmacology of Miami LLC, Miami, USA; 4. Alliance for Multispecialty Research LLC, Knoxville, USA
|
| |
|
|
|
|
|
